ArticleScientific reports2019

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis.

Isabell Schau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.